Pfizer Inc. (NYSE:PFE – Get Free Report)’s share price fell 0.8% during trading on Thursday after UBS Group lowered their price target on the stock from $31.00 to $29.00. UBS Group currently has a ...

NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2025 of $0.22 per Class A ...

Hospitals Open For Now As LA Fires Worsen: Hospitals in Los Angeles County remained operational as of Wednesday evening, though several health systems have shuttered clinical locations and physician ...

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

Range Financial Group LLC purchased a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the fourth quarter, according ...

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

(Reuters) - Wall Street's main indexes slipped on Tuesday, weighed down by technology stocks after a batch of upbeat economic ...

Pfizer Inc. closed $4.65 short of its 52-week high ($31.54), which the company reached on July 30th.

Three high-octane income stocks -- sporting an average yield of 7.93% -- can fatten investors' pocketbooks in the new year.

It would be great if Trump could do better than Biden’s 16 million new jobs in four years, maintain Biden’s GDP growth rate of 2.8%, keep unemployment around 4%, maintain or lower the average national ...

A Morningstar report revealed that US exchange-traded funds (ETFs ... (see more details here). Pfizer Inc. (NYSE:PFE) is a New York-based pharmaceutical industry company that specializes in ...

Pfizer stock (NYSE: PFE) was up 5% on Tuesday, December 17, after the company announced an optimistic outlook for 2025. The company expects its revenue to be in the range of $61 billion to $64 ...